Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence in Kidney Transplant Recipients (StopCMV: S=Sirolimus CMV= Cytomegalovirus)

Trial Profile

Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence in Kidney Transplant Recipients (StopCMV: S=Sirolimus CMV= Cytomegalovirus)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2016

At a glance

  • Drugs Sirolimus (Primary) ; Mycophenolate sodium; Prednisone; Tacrolimus
  • Indications Cytomegalovirus infections
  • Focus Therapeutic Use
  • Acronyms StopCMV
  • Most Recent Events

    • 20 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top